1. Home
  2. IART vs PCRX Comparison

IART vs PCRX Comparison

Compare IART & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

HOLD

Current Price

$19.68

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.96

Market Cap

999.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IART
PCRX
Founded
1989
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
999.0M
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
IART
PCRX
Price
$19.68
$25.96
Analyst Decision
Hold
Strong Buy
Analyst Count
7
4
Target Price
$14.33
$30.25
AVG Volume (30 Days)
900.7K
479.1K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.07
Revenue
N/A
$541,533,000.00
Revenue This Year
$4.39
$6.78
Revenue Next Year
$3.40
$8.54
P/E Ratio
N/A
$370.43
Revenue Growth
N/A
26.04
52 Week Low
$8.70
$18.80
52 Week High
$20.26
$27.64

Technical Indicators

Market Signals
Indicator
IART
PCRX
Relative Strength Index (RSI) 63.53 60.51
Support Level $10.61 $21.89
Resistance Level $20.26 $26.94
Average True Range (ATR) 0.85 0.82
MACD -0.03 -0.03
Stochastic Oscillator 85.23 56.59

Price Performance

Historical Comparison
IART
PCRX

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: